Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial

Clinical Oncology

Volumn 25, Issue 5, 2013, Pages 318-320

  Parker, C C ^a   Sydes, M R ^b   Mason, M D ^c   Clarke, N W ^d   Aebersold, D ^e   de Bono, J S ^g   Dearnaley, D P ^g   Ritchie, A W S ^b   Russell, J M ^h   Thalmann, G ^e   Parmar, M K B ^b   James, N D ^f  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h Institute of Cancer Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISTANT METASTASIS; EDITORIAL; HEALTH CARE QUALITY; HORMONAL THERAPY; HUMAN; KIDNEY CARCINOMA; MICROENVIRONMENT; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TRANSURETHRAL RESECTION; TUMOR CELL;

BONE MARROW NEOPLASMS; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS;

EID: 84876157925     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.01.005     Document Type: Editorial

References (8)

1. Warde P., Mason M., Ding K., et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011, 378:2104-2111.
2. Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009, 373(9660):301-308.
3. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.
4. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2008, 9:285-293.
5. Flanigan R.C., Salmon S.E., Blumenstein B.A., et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001, 345:1655-1659.
6. Mickisch G.H., Garin A., van Poppel H., de Prijck L., Sylvester R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001, 358:966-970.
7. Weckermann D., Polzer B., Ragg T., et al. Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. J Clin Oncol 2009, 27:1549-1556.
8. Sydes M.R., James N.D., Mason M.D., et al. Flexible trial design in practice - dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial. Trials 2011, 12(Suppl. 1):A3.